Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paclitaxel (Taxol) as salvage therapy for relapsed ovarian cancer.
Planner RS, Allen DG, Brand AH, Grant PT, Toner GC, Sykes PH. Planner RS, et al. Among authors: grant pt. Aust N Z J Obstet Gynaecol. 1996 May;36(2):168-70. doi: 10.1111/j.1479-828x.1996.tb03278.x. Aust N Z J Obstet Gynaecol. 1996. PMID: 8798307
Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.
Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group. Jordan S, et al. Gynecol Oncol. 2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9. Gynecol Oncol. 2013. PMID: 23403164 Free article.
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium. Olsen CM, et al. Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23404857 Free PMC article.
Oral cyclophosphamide in recurrent ovarian cancer.
Handolias D, Quinn M, Foo S, Mileshkin L, Grant P, Dutu G, Rischin D. Handolias D, et al. Among authors: grant p. Asia Pac J Clin Oncol. 2016 Mar;12(1):e154-60. doi: 10.1111/ajco.12074. Epub 2013 May 29. Asia Pac J Clin Oncol. 2016. PMID: 23718870
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium. Terry KL, et al. Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12. Cancer Prev Res (Phila). 2013. PMID: 23761272 Free PMC article.
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.
Gao B, Russell A, Beesley J, Chen XQ, Healey S, Henderson M, Wong M, Emmanuel C, Galletta L, Johnatty SE, Bowtell D; Australian Ovarian Cancer Study Group; Haber M, Norris M, Harnett P, Chenevix-Trench G, Balleine RL, deFazio A. Gao B, et al. Sci Rep. 2014 May 9;4:4669. doi: 10.1038/srep04669. Sci Rep. 2014. PMID: 24810093 Free PMC article.
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
Hedditch EL, Gao B, Russell AJ, Lu Y, Emmanuel C, Beesley J, Johnatty SE, Chen X, Harnett P, George J; Australian Ovarian Cancer Study Group; Williams RT, Flemming C, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Karlan B, Lester J, Orsulic S, Walsh C, Fasching P, Beckmann MW, Ekici AB, Hein A, Matsuo K, Hosono S, Nakanishi T, Yatabe Y, Pejovic T, Bean Y, Heitz F, Harter P, du Bois A, Schwaab I, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Lundvall L, Engelholm SA, Brown B, Flanagan J, Metcalf MD, Siddiqui N, Sellers T, Fridley B, Cunningham J, Schildkraut J, Iversen E, Weber RP, Berchuck A, Goode E, Bowtell DD, Chenevix-Trench G, deFazio A, Norris MD, MacGregor S, Haber M, Henderson MJ. Hedditch EL, et al. J Natl Cancer Inst. 2014 Jun 23;106(7):dju149. doi: 10.1093/jnci/dju149. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24957074 Free PMC article.
1,901 results